头孢罗林酯 T7387

Product Introduction
Bioactivity


英文名: Ceftaroline fosamil

描述: Ceftaroline fosamil (TAK-599) 是一种头孢菌素衍生物，是抗甲氧西林金黄色葡萄球菌 (MRSA) T-91825 的 N-膦酰基前药，可研究 MRSA 感染。

体内活性: Ceftaroline fosamil 600 mg given every 12 h was superior to ceftriaxone 2 g given every 24 h for the treatment of Asian patients with PORT III-IV community-acquired pneumonia. These data suggest that ceftaroline fosamil should be regarded as an alternative to ceftriaxone in empirical treatment regimens for this patient population.

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 14 mg/mL (32.22 mM)


关键字: N-phosphono | inhibit | MRSA | Ceftaroline fosamil | TAK599 | PPI-0903 | TAK 599 | PPI 0903 | T-91825 | Bacterial | Inhibitor | Antibiotic | infection | prodrug

相关产品: Sapienic acid sodium | Enmetazobactam | Ethylparaben | HPi1 | Isepamicin sulfate | Vancomycin | Mitonafide | Probenecid | Ethionamide | Sulfisoxazole acetyl

相关库: Drug Repurposing Compound Library | Approved Drug Library | Drug-induced Liver Injury (DILI) Compound Library | Clinical Compound Library | Bioactive Compounds Library Max | Beta-Lactam Compound Library | Human Metabolite Library | Pediatric Drug Library | EMA Approved Drug Library | Bioactive Compound Library

头孢罗林酯 T7387信息由TargetMol中国为您提供，如您想了解更多关于头孢罗林酯 T7387报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途